These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27613072)

  • 21. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.
    Cole KS; Martin JM; Horne WT; Lin CJ; Nowalk MP; Alcorn JF; Zimmerman RK
    Vaccine; 2017 Dec; 35(49 Pt B):6893-6897. PubMed ID: 29132989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live attenuated and inactivated influenza vaccines in children.
    Ilyushina NA; Haynes BC; Hoen AG; Khalenkov AM; Housman ML; Brown EP; Ackerman ME; Treanor JJ; Luke CJ; Subbarao K; Wright PF
    J Infect Dis; 2015 Feb; 211(3):352-60. PubMed ID: 25165161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons.
    Kahn KE; Santibanez TA; Zhai Y; Singleton JA
    Vaccine; 2015 Sep; 33(39):5196-203. PubMed ID: 26238724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study.
    Lindsey BB; Jagne YJ; Armitage EP; Singanayagam A; Sallah HJ; Drammeh S; Senghore E; Mohammed NI; Jeffries D; Höschler K; Tregoning JS; Meijer A; Clarke E; Dong T; Barclay W; Kampmann B; de Silva TI
    Lancet Respir Med; 2019 Aug; 7(8):665-676. PubMed ID: 31235405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere.
    Pebody R; McMenamin J; Nohynek H
    Arch Dis Child; 2018 Jan; 103(1):101-105. PubMed ID: 28855230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.
    Gauger PC; Loving CL; Khurana S; Lorusso A; Perez DR; Kehrli ME; Roth JA; Golding H; Vincent AL
    Virology; 2014 Dec; 471-473():93-104. PubMed ID: 25461535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Meta-analysis on effectiveness of live attenuated influenza vaccine against seasonal influenza in children].
    Tao YY; Jin PF; Zhu FC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jan; 41(1):103-110. PubMed ID: 32062951
    [No Abstract]   [Full Text] [Related]  

  • 31. Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.
    Carter NJ; Curran MP
    Drugs; 2011 Aug; 71(12):1591-622. PubMed ID: 21861544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effectiveness of trivalent inactivated influenza vaccine and live, attenuated influenza vaccine in preventing influenza-like illness among US military service members, 2006-2009.
    Phillips CJ; Woolpert T; Sevick C; Faix D; Blair PJ; Crum-Cianflone NF
    Clin Infect Dis; 2013 Jan; 56(1):11-9. PubMed ID: 23183869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
    Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study.
    Jackson ML; Ferdinands J; Nowalk MP; Zimmerman RK; Kieke B; Gaglani M; Murthy K; Petrie JG; Martin ET; Chung JR; Flannery B; Jackson LA
    BMC Public Health; 2021 Mar; 21(1):516. PubMed ID: 33726743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
    J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness.
    Fu C; Xu J; Lin J; Wang M; Li K; Ge J; Thompson MG
    Vaccine; 2015 Jun; 33(25):2917-21. PubMed ID: 25921713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revisiting live attenuated influenza vaccine efficacy among children in developing countries.
    Bagga S; Krishnan A; Dar L
    Vaccine; 2023 Jan; 41(5):1009-1017. PubMed ID: 36604216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of influenza vaccine in children in preventing influenza associated hospitalisation, 2018/19, England.
    Pebody RG; Zhao H; Whitaker HJ; Ellis J; Donati M; Zambon M; Andrews N
    Vaccine; 2020 Jan; 38(2):158-164. PubMed ID: 31648914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19.
    Pebody RG; Whitaker H; Ellis J; Andrews N; Marques DFP; Cottrell S; Reynolds AJ; Gunson R; Thompson C; Galiano M; Lackenby A; Robertson C; O'Doherty MG; Owens K; Yonova I; Shepherd SJ; Moore C; Johnston J; Donati M; McMenamin J; Lusignan S; Zambon M
    Vaccine; 2020 Jan; 38(3):489-497. PubMed ID: 31685296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.